These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8700279)

  • 1. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Innovative approaches in therapy of chronic polyarthritis].
    Keysser G; Burmester GR
    Fortschr Med; 1995 Mar; 113(7):77-80. PubMed ID: 7750887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of immunotherapy in rheumatoid arthritis].
    Lotz M
    Rev Rhum Ed Fr; 1993 Jan; 60(1):3-9. PubMed ID: 8242024
    [No Abstract]   [Full Text] [Related]  

  • 6. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.
    Bayry J; Sibéril S; Triebel F; Tough DF; Kaveri SV
    Drug Discov Today; 2007 Jul; 12(13-14):548-52. PubMed ID: 17631249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 8. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 1998; 70(5):32-7. PubMed ID: 9644739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-cytokine therapy in inflammatory joint diseases].
    Ehrenfeld M; Langevitz P; Shoenfeld Y
    Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial experience combining methotrexate with biologic agents for treating rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1996 Mar; 44():78-83. PubMed ID: 8833060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis.
    Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA
    Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis.
    Maurice MM; van der Graaff WL; Leow A; Breedveld FC; van Lier RA; Verweij CL
    Arthritis Rheum; 1999 Oct; 42(10):2166-73. PubMed ID: 10524689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis.
    Breedveld F
    Eur Cytokine Netw; 1998 Sep; 9(3):233-8. PubMed ID: 9831171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNFalpha therapy for rheumatoid arthritis: an update.
    Taylor PC
    Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.